Minovital (Minoxidil)

Minoxidil works by opening ATP‑sensitive potassium channels in the cells of hair follicles. This leads to vasodilation, improved blood flow, and enhanced delivery of oxygen and nutrients to the follicle, which prolongs the growth (anagen) phase and stimulates new hair formation.

The appropriate dose of Minovital is determined by a qualified healthcare professional. Typically, a specific amount of the topical solution is applied to the affected scalp area once or twice daily, but the exact regimen should follow the prescriber’s instructions.

The safety of minoxidil in pregnancy and lactation has not been definitively established. Women who are pregnant, planning to become pregnant, or breastfeeding should only use Minovital if clearly advised by their physician after weighing potential risks and benefits.

To order Minovital, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies, and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any necessary import documentation.

The most common alternative for androgenetic alopecia is oral finasteride, which works by inhibiting the conversion of testosterone to dihydrotestosterone. Minovital, as a topical potassium channel opener, acts locally on the scalp without systemic hormonal effects, making it suitable for patients who prefer a non‑systemic option.

Minovital should be stored at ambient temperature, preferably below 25 °C, in its original container. Keep the product away from moisture, direct sunlight, and extreme heat. Ensure the cap is tightly closed after each use to maintain product stability.

Minovital is applied directly to the clean, dry scalp. The prescribed amount is usually measured with the supplied dropper or applicator and spread evenly over the affected area. Hands should be washed after application, and the scalp should be allowed to dry before using other hair products.

Serious adverse reactions, although rare, include rapid heartbeat, chest pain, dizziness, severe allergic responses such as swelling or difficulty breathing, and significant drops in blood pressure. Users should seek immediate medical attention if any of these symptoms develop.

Minovital should be avoided by individuals with known hypersensitivity to minoxidil or any component of the formulation, those with severe cardiovascular disease without medical supervision, and anyone who is pregnant or breastfeeding unless a physician explicitly recommends its use.